Patent dispute over generic paracetamol on hold


Initial claims have been dismissed, but there is an opportunity to make further submissions on both sides GlaxoSmithKline’s legal proceeding against Apotex and Generic Partners over its paracetamol products has been dismissed, as has Apotex and Generic Partner’s cross claim. The patent claim in question covered a pharmaceutical composition comprising: “a bilayer tablet having an

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Thank Wooldridge for high vaccination rates
Next Letting your hair down